Literature DB >> 20363505

A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical research.

Frederick L Ferris1, Kellee M Miller, Adam R Glassman, Roy W Beck.   

Abstract

PURPOSE: To evaluate a logarithmic transformation of retinal thickness measurements from optical coherence tomography as a new approach to assess clinically meaningful changes in retinal thickness.
DESIGN: Methodologic, evidence-based review.
METHODS: Standard published approaches for assessing change in retinal thickness over time, as measured by optical coherence tomography (OCT), were compared with a new approach based on a logarithmic transformation of the retinal thickness data. Comparative examples were derived using published data from a clinical trial comparing intravitreal corticosteroid injections for diabetic macular edema with standard laser treatment. MAIN OUTCOME MEASURES: Comparative examples using Diabetic Retinopathy Clinical Research Network data.
RESULTS: Logarithmic transformation of retinal thickness data results in a more normalized distribution of OCT data and allows for data analyses assessing proportionate changes in retinal thickness during follow-up.
CONCLUSIONS: For analysis of grouped data, a logarithmic transformation of the OCT retinal thickness measurements (logOCT) provides several analytic advantages. Distributions of retinal thickness in groups of eyes with diabetic macular edema, and many other causes of macular thickening, tend to be skewed to the right; the logOCT transformation tends to normalize these distributions, which has value for statistical comparisons. For assessing whether the observed OCT change in a patient is real (and not due to testing variability), a 1-step log scale change exceeds the measurement error for all degrees of retinal thickness in current instruments. In addition, this log scale is similar to the logarithm of the minimum angle of resolution (logMAR) scale used for visual acuity. Steps on the log scale for change in thickness seem to be better related to clinical importance than the actual change in microns because each step on the log scale is the same proportionate change in thickness, with a 3-step change equaling a halving or doubling of thickness, regardless of the baseline value. Transformation of OCT retinal thickness data to logOCT may assist in the assessment of clinically meaningful changes in retinal thickness just as use of the logMAR scale has helped to assess clinically meaningful changes in visual acuity. Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363505      PMCID: PMC2916055          DOI: 10.1016/j.ophtha.2009.12.014

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

1.  Prospective comparison of cirrus and stratus optical coherence tomography for quantifying retinal thickness.

Authors:  Daniel F Kiernan; Seenu M Hariprasad; Eric K Chin; Claire L Kiernan; James Rago; William F Mieler
Journal:  Am J Ophthalmol       Date:  2008-10-17       Impact factor: 5.258

2.  Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema.

Authors:  Magdalena G Krzystolik; Samara F Strauber; Lloyd Paul Aiello; Roy W Beck; Brian B Berger; Neil M Bressler; David J Browning; Robert B Chambers; Ronald P Danis; Matthew D Davis; Adam R Glassman; Victor H Gonzalez; Paul B Greenberg; Jeffrey G Gross; Judy E Kim; Craig Kollman
Journal:  Ophthalmology       Date:  2007-03-13       Impact factor: 12.079

3.  Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.

Authors:  David J Browning; Adam R Glassman; Lloyd Paul Aiello; Roy W Beck; David M Brown; Donald S Fong; Neil M Bressler; Ronald P Danis; James L Kinyoun; Quan Dong Nguyen; Abdhish R Bhavsar; Justin Gottlieb; Dante J Pieramici; Michael E Rauser; Rajendra S Apte; Jennifer I Lim; Päivi H Miskala
Journal:  Ophthalmology       Date:  2006-11-21       Impact factor: 12.079

4.  A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.

Authors: 
Journal:  Ophthalmology       Date:  2008-07-26       Impact factor: 12.079

5.  Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema.

Authors:  David J Browning; Adam R Glassman; Lloyd P Aiello; Neil M Bressler; Susan B Bressler; Ronald P Danis; Matthew D Davis; Frederick L Ferris; Suber S Huang; Peter K Kaiser; Craig Kollman; Srinavas Sadda; Ingrid U Scott; Haijing Qin
Journal:  Ophthalmology       Date:  2008-08       Impact factor: 12.079

6.  Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy.

Authors:  Neil M Bressler; Allison R Edwards; Andrew N Antoszyk; Roy W Beck; David J Browning; Antonio P Ciardella; Ronald P Danis; Michael J Elman; Scott M Friedman; Adam R Glassman; Jeffrey G Gross; Helen K Li; Timothy J Murtha; Thomas W Stone; Jennifer K Sun
Journal:  Am J Ophthalmol       Date:  2008-02-21       Impact factor: 5.258

7.  Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis).

Authors:  Sandeep Grover; Ravi K Murthy; Vikram S Brar; Kakarla V Chalam
Journal:  Am J Ophthalmol       Date:  2009-05-09       Impact factor: 5.258

8.  A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol.

Authors:  Roy W Beck; Pamela S Moke; Andrew H Turpin; Frederick L Ferris; John Paul SanGiovanni; Chris A Johnson; Eileen E Birch; Danielle L Chandler; Terry A Cox; R Clifford Blair; Raymond T Kraker
Journal:  Am J Ophthalmol       Date:  2003-02       Impact factor: 5.258

  8 in total
  17 in total

1.  Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research network.

Authors:  Christina J Flaxel; Allison R Edwards; Lloyd Paul Aiello; Paul G Arrigg; Roy W Beck; Neil M Bressler; Susan B Bressler; Frederick L Ferris; Shailesh K Gupta; Julia A Haller; Howard S Lazarus; Haijing Qin
Journal:  Retina       Date:  2010-10       Impact factor: 4.256

2.  Qualitative and quantitative OCT response of diffuse diabetic macular oedema to macular laser photocoagulation.

Authors:  R Vemala; S Koshy; S Sivaprasad
Journal:  Eye (Lond)       Date:  2011-04-15       Impact factor: 3.775

3.  Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I/II clinical study.

Authors:  Catherine A Cukras; Philip Petrou; Emily Y Chew; Catherine B Meyerle; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-22       Impact factor: 4.799

4.  Influence of baseline diabetic retinopathy status on initial anatomical response of intravitreal ranibizumab therapy for diabetic macular oedema.

Authors:  L Nicholson; N V Patrao; J Ramu; C Vazquez-Alfageme; M Muwas; R Rajendram; P G Hykin; S Sivaprasad
Journal:  Eye (Lond)       Date:  2017-04-28       Impact factor: 3.775

5.  Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography.

Authors:  Elizabeth A Sugar; Douglas A Jabs; Michael M Altaweel; Sue Lightman; Nisha Acharya; Albert T Vitale; Jennifer E Thorne
Journal:  Am J Ophthalmol       Date:  2011-09-08       Impact factor: 5.258

6.  Functional characterization of peroxisome proliferator-activated receptor-β/δ expression in colon cancer.

Authors:  Jennifer E Foreman; Wen-Chi L Chang; Prajakta S Palkar; Bokai Zhu; Michael G Borland; Jennie L Williams; Lance R Kramer; Margie L Clapper; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Carcinog       Date:  2011-03-11       Impact factor: 4.784

7.  Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab.

Authors:  Susan B Bressler; Haijing Qin; Roy W Beck; Kakarla V Chalam; Judy E Kim; Michele Melia; John A Wells
Journal:  Arch Ophthalmol       Date:  2012-09

8.  Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema.

Authors:  Carl W Baker; Talat Almukhtar; Neil M Bressler; Adam R Glassman; Sandeep Grover; Stephen J Kim; Timothy J Murtha; Michael E Rauser; Cynthia Stockdale
Journal:  JAMA Ophthalmol       Date:  2013-07       Impact factor: 7.389

9.  Long-term effectiveness of vitrectomy in diabetic cystoid macular edema.

Authors:  Javier Navarrete-Sanchis; Julian Zarco-Bosquets; Juan Miguel Tomas-Torrent; Teresa Diago; Leticia Ortega-Evangelio
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-24       Impact factor: 3.117

10.  Macular edema after cataract surgery in diabetic eyes evaluated by optical coherence tomography.

Authors:  Xiao-Yong Chen; Wen-Jun Song; Hong-Yuan Cai; Lin Zhao
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.